Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1997;24(1):81–87. doi: 10.1007/BF01728316

Pulmonary technetium-99m diethylene triamine penta-acetic acid aerosol clearance as an index of lung injury

Michael J O'Doherty 1, A Michael Peters 2,✉
PMCID: PMC7102144  PMID: 9044883

Abstract

Although the clearance of an inhaled nebulised radioaerosol has long been employed as a measure of lung function, this test has not found favour in nuclear medicine units to the extent that might originally have been anticipated. In this review the theoretical basis of solute transfer is considered and the measurement of radioaerosol clearance discussed. Thereafter the various clinical applications of alveolar permeability measurement are outlined. Finally, possible reasons for the restricted clinical use of the diethylene triamine penta-acetic acid clearance technique are considered. It is concluded that the technique should provide a rapid screening evaluation of the HIV+ve patient presenting predominantly with chest symptoms.

Key words: Diethylene triamine penta-acetic acid, Aerosol, Lung injury, Alveolar epithelium

References

  • 1.Arnot RN, Takagi H, Hughes JMB, Royston D, Peters AM, Lavender JP. Lung studies with a lipophilic aerosol of99Tcm-labelled HMPAO [abstract] Nucl Med Commun. 1988;9:166. [Google Scholar]
  • 2.Chopra SK, Taplin GV, Tashkin DP, Elan D. Lung clearance of soluble aerosols of different molecular weights in systemic sclerosis. Thorax. 1979;34:63–67. doi: 10.1136/thx.34.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Effros RM, Mason GR. Measurements of pulmonary epithelial permeability in vivo. Am Rev Respir Dis. 1983;127(Suppl):S-59–S-65. [PubMed] [Google Scholar]
  • 4.Jones JG, Royston D, Minty BD. Changes in alveolar-capillary barrier function in animals and humans. Am Rev Respir Dis. 1983;127(Sppl):S-51–S-59. [PubMed] [Google Scholar]
  • 5.Braude S, Nolop KB, Hughes JMB, Barnes PJ, Royston D. Comparison of lung vascular and epithelial permeability indices in the adult respiratory distress syndrome. Am Rev Respir Dis. 1986;133:1002–1005. doi: 10.1164/arrd.1986.133.6.1002. [DOI] [PubMed] [Google Scholar]
  • 6.Coates G, O'Brodovich H. Measurement of pulmonary epithelial permeability with Tc-99m DTPA aerosol. Semin Nucl Med. 1986;16:275–284. doi: 10.1016/s0001-2998(86)80014-9. [DOI] [PubMed] [Google Scholar]
  • 7.Mason GR, Duane GB, Mena I, Effors RM. Accelerated solute clearance inPneumocystis carinii pneumonia.Am Rev Respir Dis 1987; 864–868. [DOI] [PubMed]
  • 8.Miller RF, O'Doherty M. Pulmonary nuclear medicine. Eur J Nucl Med. 1992;19:355–368. doi: 10.1007/BF00177058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.West JB. Uptake and delivery of the respiratory gases. In: West JB, editor. Physiological basis of medical practice. Baltimore: Williams & Wilkins; 1985. pp. 546–571. [Google Scholar]
  • 10.Rizk NW, Luce JM, Hoeffel JM, Price DC, Murray JF. Site of deposition and factors affecting clearance of aerosolized solute from canine lungs. J Appl Physiol. 1984;56:723–729. doi: 10.1152/jappl.1984.56.3.723. [DOI] [PubMed] [Google Scholar]
  • 11.Barrowcliffe MP, Zanelli GD, Jones JG. Pulmonary clearance of radiotracers after positive end-expiratory pressure or acute lung injury. J Appl Physiol. 1989;66:288–294. doi: 10.1152/jappl.1989.66.1.288. [DOI] [PubMed] [Google Scholar]
  • 12.Marks JD, Luce JM, Lazar NM, Ngao-Sun W, Lipavsky A, Murray JF. Effects of increases of lung volume on clearance of aerosolized solute from human lungs. J Appl Physiol. 1985;59:1242–1248. doi: 10.1152/jappl.1985.59.4.1242. [DOI] [PubMed] [Google Scholar]
  • 13.Gil J, Bachofen H, Gehr P, Weibel ER. Alveolar volume — surface area relation in air- and saline-filled lungs fixed by vascular perfusion. J Appl Physiol. 1979;47:990–1001. doi: 10.1152/jappl.1979.47.5.990. [DOI] [PubMed] [Google Scholar]
  • 14.Evander E, Wollmer P, Jonson B, Lachman B. Pulmonary clearance of inhaled Tc-99m-DTPA: effect of surfactant depletion by lavage. J Appl Physiol. 1987;62:1611–1614. doi: 10.1152/jappl.1987.62.4.1611. [DOI] [PubMed] [Google Scholar]
  • 15.Mason GR, Effros RM, Uszler JM, Mena I. Small solute clearance from the lungs of patients with cardiogenic and noncardiogenic edema. Chest. 1985;88:327–334. doi: 10.1378/chest.88.3.327. [DOI] [PubMed] [Google Scholar]
  • 16.Coates G, O'Brodovich H, Dolovich M. Lung clearance of99mTc-DTPA in patients with acute lung injury and pulmonary edema. J Thorac Imag. 1988;3:21–27. doi: 10.1097/00005382-198807000-00008. [DOI] [PubMed] [Google Scholar]
  • 17.Jones JG, Minty BD, Lawler P, Hulands G, Crawley JC, Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet. 1980;I:66–68. doi: 10.1016/s0140-6736(80)90493-6. [DOI] [PubMed] [Google Scholar]
  • 18.Dusser DJ, Minty BD, Collignon M-AG, Hinge D, Barritault LG, Huchon GJ. Regional respiratory clearance of aerosolized Tc-99m DTPA: posture and smoking effects. J Appl Physiol. 1986;60:2000–2006. doi: 10.1152/jappl.1986.60.6.2000. [DOI] [PubMed] [Google Scholar]
  • 19.Huchon GJ, Montgomery AB, Lipavsky A, Hoeffel JM, Murray JF. Respiratory clearance of aerosolized radioactive solutes of varying molecular weight. J Nucl Med. 1987;28:894–902. [PubMed] [Google Scholar]
  • 20.Mason GR, Peters AM, Bagdades E, Snook D, Hughes JMB. Effect of molecular size on radio-aerosol clearance [abstract] J Nucl Med. 1992;33:1022. [Google Scholar]
  • 21.Egan EA, Oliver RE, Strang LB. Changes in the non-electrolyte permeability of alveoli and the absorption of lung liquid at the onset of breathing. J Physiol. 1975;244:161–179. doi: 10.1113/jphysiol.1975.sp010789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Egan EA, Nelson RM, Oliver RE. Lung inflation and alveolar permeability to non-electrolytes in the adult sheep in vivo. J Physiol. 1976;260:409–424. doi: 10.1113/jphysiol.1976.sp011522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Egan EA. Response of alveolar epithelial solute permeability to changes in lung inflation. J Appl Physiol. 1980;49:1032–1036. doi: 10.1152/jappl.1980.49.6.1032. [DOI] [PubMed] [Google Scholar]
  • 24.Peters AM, Mason GR, Hughes JMB. Appropriate background subtraction for pulmonary radioaerosol clearance [abstract] J Nucl Med. 1992;33:836. [Google Scholar]
  • 25.Bourke SJ, Banham SW, McKillop JH, Boyd G. Clearance of99mTc-DTPA in pigeon fancier's hypersensitivity pneumonitis. Am Rev Respir Dis. 1990;142:1168–1171. doi: 10.1164/ajrccm/142.5.1168. [DOI] [PubMed] [Google Scholar]
  • 26.Rinderknecht J, Shapiro L, Krauthammer M, et al. Accelerated clearance of small solvents from the lungs in interstitial lung disease. Am Rev Respir Dis. 1980;121:105–117. doi: 10.1164/arrd.1980.121.1.105. [DOI] [PubMed] [Google Scholar]
  • 27.Labrune S, Chinet TH, Collignon L, Barritault L, Huchon GJ. Mechanisms of increased epithelial lung clearance of DTPA in diffuse fibrosing alveolitis. Eur Respir J. 1994;7:651–656. doi: 10.1183/09031936.94.07040651. [DOI] [PubMed] [Google Scholar]
  • 28.Wells AU, Hansell DM, Harrison NK, et al. Clearance of inhaled99mTc DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J. 1993;6:797–802. [PubMed] [Google Scholar]
  • 29.Uh S, Lee SM, Kim HT, Chung Y, Kim YH, Park CS. The clearance rate of alveolar epithelium using99mTc-DTPA in patients with diffuse infiltrating lung disease. Chest. 1994;106:161–165. doi: 10.1378/chest.106.1.161. [DOI] [PubMed] [Google Scholar]
  • 30.Chinet T, Jaubert F, Dusser D, Danel C, Chretien J, Huchon GJ. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax. 1990;45:675–678. doi: 10.1136/thx.45.9.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Dusser DJ, Collignon MA, Stanislas-Leguern G, Barritault LG, Chretien J, Huchon GJ. Respiratory clearance of99mTc DTPA and pulmonary involvement in sarcoidosis. Am Rev Respir Dis. 1986;134:493–497. doi: 10.1164/arrd.1986.134.3.493. [DOI] [PubMed] [Google Scholar]
  • 32.Watanabe N, Inoue T, Oriuchi H, Suzuki H, Hirano T, Endo K. Increased pulmonary clearance of aerosolized99mTc DTPA in patients with a subset of stage I sarcoidosis. [DOI] [PubMed]
  • 33.Terra-Filho M, Vargas FS, Meneguetti JC, et al. Pulmonary clearance of technetium 99m diethylene triamine penta acetic acid aerosol in patients with amiodarone pneumonitis. Eur J Nucl Med. 1990;17:334–337. doi: 10.1007/BF01268025. [DOI] [PubMed] [Google Scholar]
  • 34.Susskind H, Weber DA, Volkow ND, et al. Increased lung permeability following long-term use of free-base cocaine (crack) Chest. 1991;100:903–909. doi: 10.1378/chest.100.4.903. [DOI] [PubMed] [Google Scholar]
  • 35.Basran GS, Byrne AJ, Hardy JG. A non-invasive technique for monitoring lung vascular permeability in man. Nucl Med Commun. 1985;3:3–10. doi: 10.1097/00006231-198501000-00002. [DOI] [PubMed] [Google Scholar]
  • 36.Braude S, Apperley J, Krausz T, Goldman JM, Royston D. Adult respiratory distress syndrome after allergic bone marrow transplantation: evidence for a neutrophil independent mechanism. Lancet. 1985;I:1239–1242. doi: 10.1016/s0140-6736(85)92312-8. [DOI] [PubMed] [Google Scholar]
  • 37.Murray JF, Garay SM, Hopewell PC, Mills J, Snider GL, Stover DE. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Am Rev Respir Dis. 1987;135:504–509. doi: 10.1164/arrd.1987.135.2.504. [DOI] [PubMed] [Google Scholar]
  • 38.O'Doherty MJ, Breen D, Page CJ, Barton I, Nunan TO. Lung99mTc DTPA transfer in renal disease and pulmonary infection. Nephrol Dial Transplant. 1991;6:582–587. doi: 10.1093/ndt/6.8.582. [DOI] [PubMed] [Google Scholar]
  • 39.O'Doherty MJ, Page CJ, Bradbeer CS, et al. Alveolar permeability in HIV patients withPneumocystis carinii pneumonia. Genitourin Med. 1987;63:268–270. doi: 10.1136/sti.63.4.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rosso J, Guillon JM, Parrot A, et al. Technetium-99m-DTPA aerosol and gallium-67 scanning in pulmonary complications of human immunodeficiency virus infection. J Nucl Med. 1992;33:81–87. [PubMed] [Google Scholar]
  • 41.O'Doherty MJ, Page CJ, Radbeer CS, et al. The place of lung99mTc DTPA aerosol transfer in the investigation of lung infections in HIV+ve patients. Resp Med. 1989;83:395–401. doi: 10.1016/s0954-6111(89)80071-x. [DOI] [PubMed] [Google Scholar]
  • 42.Leach R, Davidson C, O'Doherty MJ, Nayagam M, Tang A, Bateman N. Non-invasive management of fever and breathlessness in HIV+ve patients. Eur J Resp Med. 1991;4:19–25. [PubMed] [Google Scholar]
  • 43.Van der Wall H, Murray IPC, Jones PD, Mackey DWJ, Walker BM, Monaghan P. Optimising technetium-99m diethylene triamine-penta-acetate lung clearance in patients with the acquired immunodeficiency syndrome. Eur J Nucl Med. 1991;18:235–240. doi: 10.1007/BF00186646. [DOI] [PubMed] [Google Scholar]
  • 44.Robinson PS, Cunningham DA, Dave S, Fleming J, Mitchell DM. Diagnostic value of lung clearance of99mTc DTPA compared with other non-invasive investigations inPneumocystis carinii pneumonia in AIDS. Thorax. 1991;46:722–726. doi: 10.1136/thx.46.10.722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.O'Doherty MJ. 99mTc DTPA transfer/permeability in patients with HIV disease. Q J Nucl Med. 1995;39:231–242. [PubMed] [Google Scholar]
  • 46.Lisbona R, Hakim TS, Dean GW, et al. Regional pulmonary perfusion following heart/lung transplantation. J Nucl Med. 1989;30:1297–1301. [PubMed] [Google Scholar]
  • 47.Skeens JL, Fuhrman CR, Yousem SA. Bronchiolitis obliterans in heart-lung transplantation patients. AJR. 1989;153:253–256. doi: 10.2214/ajr.153.2.253. [DOI] [PubMed] [Google Scholar]
  • 48.Herve PA, Silbert D, Mensch J, et al. Increased lung clearance of99mTc DTPA in allograft lung rejection. The Paris-Sud Lung Transplant Group. Am Rev Respir Dis. 1991;144:1333–1336. doi: 10.1164/ajrccm/144.6.1333. [DOI] [PubMed] [Google Scholar]

Articles from European Journal of Nuclear Medicine are provided here courtesy of Nature Publishing Group

RESOURCES